Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. Compare
  3. Hims vs Fridays
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 06, 2026
Hims telehealth platform
Hims
VS
Fridays telehealth platform
Fridays
Visit HimsVisit Fridays

Hims vs Fridays

Complete 2026 Comparison for Weight Loss, Testosterone Replacement Therapy

Weight LossTestosterone Replacement Therapy

Our Verdict

The cheaper brand flips between the two categories. Testosterone: Hims from $99 a month as of 2026-09-12, Fridays from $129 a month on an undated figure in our records, with Fridays itemizing a Quest or LabCorp biomarker assessment that Hims does not describe. Weight loss: Fridays from $150 a month as of 2026-09-12 for compounded semaglutide on a prepaid plan, against Hims from $298 a month as of 2026-09-12, which is the medication tier plus the required membership on top of it. Compounded products carry no FDA approval. Hims is covered by an open FDA warning letter; our file holds no regulatory note for Fridays.

Pick Hims

you want the lowest entry price on testosterone care, $99 a month as of 2026-09-12, with providers in all 50 states and FSA or HSA eligibility, or you want a weight loss lineup described as including name-brand FDA-approved options and will accept the higher combined floor once the required membership is counted. It is not for you if you have been diagnosed with prostate cancer or have severe untreated sleep apnea, and the weight loss program excludes pregnancy and a BMI under 27 with no qualifying condition.

Pick Fridays

you want to see what the plan includes before paying for it: injectable testosterone from $129 a month, with a baseline biomarker assessment through Quest Diagnostics or LabCorp and clinician review of your labs first, or compounded semaglutide from $150 a month as of 2026-09-12 if a prepaid plan and a product with no FDA approval are acceptable to you. United States only, and not for you if you have been diagnosed with prostate or breast cancer.

Hims wins on testosterone price, but Fridays is the only one of the two that says what the testosterone plan includes. On weight loss the order reverses: Fridays from $150 a month for compounded semaglutide on a prepaid plan, against $298 at Hims once its required $149 membership is added to its $149 medication tier. The gap is a compounded product against one described as including approved brand names. Hims carries an open FDA warning letter about compounded GLP-1 marketing.

Quick Answer

Best overallHims

Hims is our overall pick for weight loss, based on our rating and feature coverage.

Top Weight Loss Providers

Our Top Choice
1
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review

Provider Overview

Hims logo
9.4

Our editorial rating 9.4/10Trustpilot: 2.9/5 from 9,686 reviews, checked Nov 1, 2026

Hims is one of the largest men's telehealth platforms in the US, offering treatments for ED, hair loss, weight loss, mental health, and skincare. Known for affordable pricing and modern branding.

Rating9.4/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2017
HQSan Francisco, CA
TickerHIMS
Visit HimsRead Full Review
Fridays logo
9.2

Our editorial rating 9.2/10Trustpilot: 4.1/5 from 5,192 reviews, checked Nov 1, 2026

Fridays is a GLP-1 weight loss telehealth platform offering compounded semaglutide from $150/mo and tirzepatide, plus brand-name Ozempic and Zepbound, with an insurance concierge, FSA/HSA eligibility, and bundled dietitian and coaching support.

Rating9.2/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2023
HQUnited States
Visit FridaysRead Full Review
VS

Feature Comparison

Feature comparison between Hims and Fridays
FeatureHimsHimsFridaysFridays
Rating9.4/109.2/10
Founded20172023
Free ConsultationYesYes
Free ShippingYesYes
Accepts InsuranceNoNo
HSA/FSA AcceptedYesYes
Mobile AppYesNo
Consultation TypeAsynchronous, Video (optional)Asynchronous
Shipping Time2-5 business days3-5 business days

Pricing Comparison

Pricing comparison between Hims and Fridays across treatment categories
TreatmentHimsFridays
Weight Loss$298/month$150/month
Testosterone Replacement Therapy$99/month$129/month

Prices shown are starting costs. Actual pricing varies by treatment plan and medication.

Pros and Cons

Hims

Pros

  • Affordable ED medication starting at $22/month
  • Wide range of treatment categories
  • User-friendly app and website
  • Free consultations and shipping
  • Publicly traded company with strong reputation
  • Chewable ED options available

Cons

  • Does not accept insurance
  • Subscription model for most treatments
  • Limited in-person support
  • FDA warning for weight loss claims (Sept 2024)
Fridays

Pros

  • Compounded semaglutide from $150/mo on a prepaid plan
  • Both compounded and brand-name medications available
  • Insurance concierge to maximize coverage
  • FSA/HSA approved
  • Bundled dietitians, coaching, and support groups
  • GLP-1 microdosing option

Cons

  • $150/mo requires a prepaid plan; month-to-month is $249/mo
  • Compounded medications are not FDA-approved
  • Broad wellness brand rather than a single focus
  • Best pricing rewards long plans

Which Should You Choose?

HimsChoose Hims if you:
  • Men seeking affordable ED treatment
  • First-time telehealth users
  • Those wanting one platform for multiple conditions
  • Tech-savvy patients preferring app-based care
Visit Hims
FridaysChoose Fridays if you:
  • Value-seekers who want low compounded GLP-1 pricing
  • People without GLP-1 insurance coverage
  • Those who want bundled coaching and accountability
  • Anyone wanting a microdosing on-ramp
Visit Fridays

Who This Is For

This is for
  • You want to compare medication options, monthly costs, and state availability across multiple telehealth providers.
  • You prefer reviewing licensed provider programs independently before committing to a subscription.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

About This Comparison

Our Editorial Standards

This hims vs fridays provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 6, 2026
Licensed Providers OnlyAll listed services are US-licensed

Hims vs Fridays: The Cheaper One Changes With the Category

Eric GoldWritten by Eric GoldEditor-in-Chief
13 min readUpdated October 6, 2026

Table of Contents

Which of these two is cheaper depends on which treatment you came for, and the answer reverses between the two categories they share. On testosterone, Hims is the lower of the pair, from $99 a month as of 2026-09-12. Fridays lists injectable care from $129 a month, a figure we hold with no verification date. On weight loss, it flips hard: Fridays from $150 a month as of 2026-09-12 on prepaid plans, against Hims from $298 a month as of 2026-09-12 once the required membership is counted alongside the medication. There are two things to carry into the detail below. Our Fridays testosterone figure has no verification date attached in our records, so treat it as the number to re-check on joinfridays.com. And the regulatory histories are not symmetrical: Hims is covered by an open FDA warning letter, and our file holds none for Fridays.

The cheaper brand changes when you change category

Treat these as two separate comparisons that happen to involve the same two companies, because the ranking does not survive the move from one category to the other.
Testosterone first. Hims lists testosterone support and optimization from $99 a month as of 2026-09-12, with a free consultation and free shipping in that offer. Fridays lists injectable testosterone from $129 a month. Our records carry no verification date against that Fridays figure, which is why you will not see one printed next to it anywhere on this page: naming a price is fair, dating a price we have not dated would not be. On the numbers we hold, Hims is $30 a month lower at the entry point.
Weight loss reverses it, and by a much wider margin. Fridays lists compounded semaglutide from $150 a month as of 2026-09-12 on prepaid plans. The Hims weight loss floor is $148 a month above it, and the two floors are not even describing the same kind of product, which the next sections unpack.
Both figures in each pair are catalog floors. They tell you the cheapest way in, not the cost of the plan a clinician ends up writing, and in the Hims weight loss case the floor is already the sum of two separate charges.
  • Testosterone: Hims from $99/mo as of 2026-09-12; Fridays from $129/mo, undated in our records
  • Weight loss: Fridays from $150/mo as of 2026-09-12 on prepaid plans; Hims from $298/mo as of 2026-09-12
  • Both services list cancel anytime with no commitment

Fridays itemizes the testosterone plan, Hims does not

The $30 that separates the two entry prices buys a documentation difference, and on the evidence we hold it runs in Fridays' favor even though Fridays is the pricier one.
Fridays tells you what is in the plan. The injectable tier includes a free biomarker assessment through Quest Diagnostics or LabCorp, licensed US clinicians review your lab results before writing a treatment plan, and the pricing is listed as transparent with free shipping and no commitment so you can cancel anytime. If you would rather not inject, daily enclomiphene capsules are listed from $169 a month.
Hims tells you considerably less. Our record for its testosterone program lists testosterone support and optimization, licensed providers in all 50 states, FSA and HSA eligibility, and cancel anytime with no commitment. It does not say which formats are offered, whether labs are included, or what else that figure covers. We are not going to fill those blanks in from the fact that Hims is a large company, so if labs or format matter to you, that is a question for Hims before you enroll.
Where both are explicit is on who should not start. Each lists a diagnosis of prostate cancer as a reason not to proceed, Hims adds severe untreated sleep apnea and Fridays adds breast cancer, and both rule out anyone who needs in-person injections or hands-on monitoring. Fridays is United States only.
  • Fridays $129 tier, listed: baseline biomarker assessment via Quest Diagnostics or LabCorp, clinician review of labs before a plan, free shipping
  • Fridays alternative: enclomiphene daily capsules from $169/mo
  • Hims $99 tier, listed: licensed providers in all 50 states, FSA and HSA eligible, free consultation and free shipping
  • Not in our Hims record: formats offered, whether labs are included, what else the $99 covers

Enclomiphene is the capsule, and it has no FDA approval

Fridays' route away from needles is enclomiphene, listed from $169 a month as daily capsules. Before that appeals to you on convenience alone, two facts belong on the table.
Enclomiphene is not an FDA-approved product. That is a status statement rather than a judgment: no FDA review of a finished enclomiphene product stands behind it. Injectable testosterone is the opposite case, since testosterone cypionate injections are FDA-approved. So within the Fridays lineup, the cheaper tier is the approved one and the premium capsule tier is not.
Our records also do not say whether the Fridays enclomiphene is compounded, and we are not going to guess, because the answer determines what disclosure should accompany it. Ask before you order. If a formula is compounded, it carries no FDA approval and the FDA has not reviewed it for safety, effectiveness or quality.
Fridays positions the capsule as the option for avoiding injections. We are not going to extend that into a claim about what it does in the body: that belongs to the licensed clinician who reviews your labs, and both services route you through one.

Compounded at $150, or $298 once the membership is counted

The weight loss gap looks enormous until you notice the two prices describe different products, after which it looks like what it is: a choice between a compounded medicine and an approved one.
Fridays lists compounded semaglutide from $150 a month as of 2026-09-12, with tirzepatide from $198 a month. Two conditions sit on that price. It is a prepaid plan price, so it is the cost of committing up front rather than a month-to-month rate, and the product is compounded, which means it carries no FDA approval and the FDA has not reviewed it for safety, effectiveness or quality. Fridays also lists an insurance concierge that works to maximize your coverage, a GLP-1 microdosing option, and a discount applied with codes at checkout. Check the current offer on its own site, because a promotional price moves.
Hims is the higher floor and the more conventional product. Its weight loss lineup is described as including name-brand FDA-approved options, with oral GLP-1 from $149 a month and semaglutide from $199 a month, alongside a required membership at that same monthly rate. Adding those two required charges is where the $298 floor comes from. Read the advertised medication price as half the bill rather than the bill.
One caution on the Hims side. Our record says the lineup includes name-brand FDA-approved options without specifying which of the $149 oral and $199 semaglutide tiers are brand name, and the FDA warning letter below concerns how Hims marketed a compounded semaglutide. So do not assume the cheapest Hims tier is an approved brand-name product. Ask which specific medication a given price buys.
Hims also publishes who it will not treat on this program: not during pregnancy, not with an active eating disorder without clinical review first, and not at a BMI under 27 with no qualifying weight-related condition.
  • Fridays: compounded semaglutide from $150/mo as of 2026-09-12 on prepaid plans, tirzepatide from $198/mo
  • Hims: oral GLP-1 from $149/mo plus a required $149/mo membership, which is the $298/mo floor as of 2026-09-12
  • Hims: semaglutide listed from $199/mo, before the membership
  • Compounded medicines carry no FDA approval and have not been reviewed by the FDA for safety, effectiveness or quality

Hims has an open FDA letter and our file holds none for Fridays

On September 9, 2025 the FDA sent Hims and Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: one that compared the compounded product's active ingredient to two approved brand-name medicines, and one that asserted clinical proof for its ingredients. Compounded drug products are not FDA-approved, and the agency said phrasing of that sort suggests otherwise, which is what makes the products misbranded under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. A companion letter went to the same company that day for its Hers brand. We checked FDA's warning letter index for MARCS-CMS 716567 on October 6, 2026: it listed no response letter and no close-out letter, so the letter has not been closed out.
Our records carry no regulatory note for Fridays. That is the absence of an entry in our file, which is a weaker statement than a clean record, and we did not run an independent regulatory search for this page. Do not read it as clearance.
What the letter is useful for is reading prices. It concerns a compounded GLP-1 being described in terms that implied approval it did not have, and the weight loss section above turns on exactly that distinction between a compounded product and an approved one. The practical takeaway is to make a company name the specific medication behind a specific price, in writing, before you pay for it.

How We Compared Hims vs Fridays

How we priced this comparison

Every figure here comes from our own brand records for Fridays and Hims, each carrying the date we last checked it. Where a figure is dated, we print the date. The Fridays testosterone floor of $129 a month has no verification date in our records, so we name the number and attach no date to it, and we tell you to re-check it at the source rather than dressing it up as confirmed.

Where a floor is the sum of two charges, we show the addition: $149 for the cheapest Hims medication tier plus the required membership is the floor we publish. Where a floor depends on a condition, we name the condition, which is why the Fridays weight loss floor is described as a prepaid plan price. We do not average promotional and standard pricing into a single number, and we do not plan around sale codes.

Where our records are silent, this page says so: the formats behind the Hims testosterone tier, whether labs are included in it, whether Fridays' enclomiphene is compounded, and HSA or FSA acceptance at Fridays. Silence is reported as silence.

The regulatory section is drawn from FDA warning letter records, identified by MARCS-CMS number and date, with status reported as the agency's own index shows it, including the absence of a close-out letter. We paraphrase the marketing language at issue rather than repeat it.

Final Verdict: Hims vs Fridays

The verdict

There is no single winner here, and anyone who tells you otherwise has picked one category and ignored the other.

For testosterone, Hims is cheaper at the entry point, from $99 a month as of 2026-09-12, and it lists providers in all 50 states plus FSA and HSA eligibility. Fridays asks $30 more, listing injectable care on a figure we hold with no verification date, and it tells you considerably more about what you get for it: a baseline biomarker assessment through Quest Diagnostics or LabCorp, and a clinician reviewing your labs before a plan is written. If you want to know what you are buying before you buy it, that $30 is doing real work. Re-check the Fridays figure on the site, because ours is undated.

For weight loss, Fridays is the cheaper route by a wide margin, from $150 a month as of 2026-09-12, and the reason is in the product: it is compounded semaglutide on a prepaid plan, so it carries no FDA approval and no FDA review for safety, effectiveness or quality. Hims starts at $298 a month as of 2026-09-12 because its cheapest medication tier comes with a required membership you cannot decline, and its lineup is described as including name-brand FDA-approved options. That is the trade: roughly half the price, or a product with an approval behind it.

One asymmetry to hold onto. Hims carries an open FDA warning letter about how a compounded GLP-1 was marketed, and our file holds no regulatory note for Fridays, which is an empty record rather than a clearance. In both cases the defense is the same and it is boring: make the company name the exact medication behind the exact price, and get it in writing before you pay.

Visit HimsVisit Fridays

Frequently Asked Questions

Is Fridays or Hims cheaper for testosterone treatment?

Hims, on the figures we hold: from $99 a month as of 2026-09-12, against Fridays from $129 a month for injectable care. Our Fridays testosterone figure carries no verification date in our records, so check it on joinfridays.com before you plan around it. The $30 gap also buys different amounts of disclosure, since Fridays itemizes a baseline biomarker assessment through Quest Diagnostics or LabCorp and Hims does not state what its entry price includes.

Why is the Hims weight loss price here $298 when the advertising says $149?

Because the membership is separate and required. Hims lists oral GLP-1 options from $149 a month and a required membership billed at that same rate, which together make the $298 floor in our records as of 2026-09-12. The advertised figure is the medication alone.

Does the Fridays testosterone price include lab work?

Fridays lists a free biomarker assessment through Quest Diagnostics or LabCorp with its injectable tier, and says licensed US clinicians review your lab results before writing a treatment plan. Our Hims record does not say whether labs are included in its entry tier, so we are not going to claim either way.

Is Fridays' semaglutide FDA approved?

No. Fridays lists it as compounded semaglutide, from $150 a month as of 2026-09-12 on prepaid plans. Compounded medicines carry no FDA approval, and the FDA has not reviewed them for safety, effectiveness or quality. Hims describes its own lineup as including name-brand FDA-approved options, though our record does not say which price tier buys which product, so ask Hims to name the medication behind the figure you are quoted.

Can I take a capsule instead of a testosterone injection with Fridays?

Fridays lists daily enclomiphene capsules from $169 a month as its non-injection route. Enclomiphene is not an FDA-approved product, and our records do not say whether the Fridays version is compounded, so ask before ordering. Testosterone cypionate injections, by contrast, are FDA-approved.

Does Hims accept HSA or FSA funds?

Our record lists the Hims testosterone program as FSA and HSA eligible. We hold no HSA or FSA note for Fridays in either category, so treat that as unverified rather than as a no.

What is the FDA warning letter about Hims?

MARCS-CMS 716567, sent to Hims and Hers Health, Inc. on September 9, 2025 after a review of hims.com the previous month. It concerns two marketing lines used for a compounded semaglutide, and the agency cited misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act because compounded drug products hold no FDA approval. We checked FDA's warning letter index for MARCS-CMS 716567 on October 6, 2026: it listed no response letter and no close-out letter, so the letter has not been closed out. Our records carry no regulatory note for Fridays, which is not the same as a clearance.

Can I cancel either plan?

Both say so. Fridays lists no commitment so you can cancel anytime, in its testosterone listing. Hims lists cancel anytime with no commitment. If you take the Fridays prepaid weight loss plan, bear in mind that prepaying and canceling anytime are different promises, so confirm how a prepaid term is refunded before you commit.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

    Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

    Related Comparisons

    HimsVSHersHimsVSRoHimsVSKeepsHimsVSNurxHimsVSHenry MedsHimsVSPlushCare

    Start With a Top Weight Loss Provider

    Our Top Choice
    1
    TrimRx logo

    GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

    • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
    • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
    • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
    • Free tracked shipping straight to your door after approval
    TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
    9.4
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    Most Popular
    2
    Medvi logo

    No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

    • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
    • Free dietician visits and care coaching included with your plan
    • Doctor-formulated plans adjusted as your body responds
    • Fast, discreet shipping to your door
    LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    3
    Fridays logo

    Compounded Semaglutide From $150/mo on Prepaid Plans

    • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
    • Insurance concierge works to maximize your coverage
    • GLP-1 microdosing option and a custom plan in under 3 minutes
    Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review

    Related Resources

    Brand Review

    Hims Review

    Brand Review

    Fridays Review

    Brand Review

    Is Hims Legit?

    Brand Review

    Is Fridays Legit?

    Guide

    Hims Alternatives

    Guide

    Fridays Alternatives

    Eric Gold
    Eric GoldEditor-in-Chief

    Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

    Medical Disclaimer: The information on this page is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting any treatment. Read our full medical disclaimer.

    How we scoreOur 1 to 10 brand scores are our own editorial judgment. They are not aggregated from third-party review platforms and they are not the output of a scoring formula.

    What a starting price isA starting price is the lowest figure a company lists for a category, not a quote. What you pay follows a clinician's review of your intake, and where a required membership or care plan sits alongside the medication we publish the two charges combined.

    Reading a warning letterA close-out letter is FDA's record that it has evaluated a company's corrective actions, so the absence of one means the file is not closed on the public record, and nothing more than that.

    Regulatory noticeRegulatory note (verified October 31, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter

    Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter